Role of human papillomavirus and cell cycle-related variants in squamous cell carcinoma of the oropharynx

Vokes, 1993, Head and neck cancer, N Engl J Med, 328, 184, 10.1056/NEJM199301213280306 Jemal, 2006, Cancer statistics 2006. Ca, Ca Cancer J Clin, 56, 106, 10.3322/canjclin.56.2.106 Carvalho, 2005, Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database, Int J Cancer, 114, 806, 10.1002/ijc.20740 Calais, 1999, Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma, J Natl Cancer Inst, 91, 2081, 10.1093/jnci/91.24.2081 Bensadoun, 2006, French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemo-therapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC), Int J Radiat Oncol Biol Phys, 64, 983, 10.1016/j.ijrobp.2005.09.041 Shiboski, 2005, Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20–44 years, Cancer, 103, 1843, 10.1002/cncr.20998 Chaturvedi, 2007, Inci-dence trends for human papillomavirus-related (HPV-R) and unrelated (HPV-U) head and neck squamous cell carcinomas (HNSCC) in the United States (US), J Clin Oncol, 2007 ASCO Annual Meeting Proceedings Part I, 25, 6001 Geijersstam, 1998, Trends in seroprevalence of human papillomavirus type 16 among pregnant women in Stockholm, Sweden, during 1969–1989, Int J Cancer, 76, 341, 10.1002/(SICI)1097-0215(19980504)76:3<341::AID-IJC10>3.0.CO;2-E Kreimer, 2004, Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus, J Infect Dis, 189, 686, 10.1086/381504 Schwartz, 1998, Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection, J Natl Cancer Inst, 90, 1626, 10.1093/jnci/90.21.1626 Mosher, 2005, Sexual behavior and selected health measures. Men and women 15–44 years of age, United States, 2002, 362 Hammarstedt, 2006, Human papillomavi-rus as a risk factor for the increase in incidence of ton-sillar cancer, Int J Cancer, 119, 2620, 10.1002/ijc.22177 Ernster, 2007, Rising incidence of oropharyn-geal cancer and the role of oncogenic human papilloma-virus, Laryngoscope, 117, 2115, 10.1097/MLG.0b013e31813e5fbb Scully, 2000, Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control, Oral Oncol, 36, 256, 10.1016/S1368-8375(00)00007-5 Yang, 2000, p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours, Nature, 404, 99, 10.1038/35003607 Street, 1995, The role of p53 and HPV in cervical cancer, Gynecol Oncol, 58, 287, 10.1006/gyno.1995.1231 Tjalma, 2004, Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer, Int J Gynecol Cancer, 14, 751, 10.1111/j.1048-891X.2004.014505.x Crook, 1991, Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and transactivation, Cell, 67, 547, 10.1016/0092-8674(91)90529-8 Vousden, 2002, Live or let die: the cell's response to p53, Nature Rev Cancer, 2, 594, 10.1038/nrc864 Chellappan, 1992, Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product, Proc Natl Acad Sci USA, 89, 4549, 10.1073/pnas.89.10.4549 Gillison, 2000, Evidence for a causal association beween human papillomavirus and a subset of head and neck cancers, J Natl Cancer Inst, 92, 709, 10.1093/jnci/92.9.709 Balz, 2003, Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2–11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens, Cancer Res, 63, 1188 Ritchie, 2003, Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx, Int J Cancer, 104, 336, 10.1002/ijc.10960 Klussmann, 2003, Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus, Am J Pathol, 162, 747, 10.1016/S0002-9440(10)63871-0 Gillison, 1999, Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease?, Cur Opin Oncol, 11, 191, 10.1097/00001622-199905000-00010 Herrero, 2003, Human papillomavirus and oral cancer: the international agency for research on cancer multicenter study, J Natl Cancer Inst, 95, 1772, 10.1093/jnci/djg107 Mork, 2001, Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck, N Engl J Med, 344, 1125, 10.1056/NEJM200104123441503 Strome, 2002, Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations, Clin Cancer Res, 8, 1093 Smith, 1998, Human papillomavirus and risk of oral cancer, Laryngoscope, 108, 1098, 10.1097/00005537-199807000-00027 Chang, 2002, Pathologi-cal features of betel quid-related oral epithelial lesions in taiwan with special emphasis on the tumor progression and human papillomavirus association, Oncol, 63, 362, 10.1159/000066227 Dahlstrom, 2003, Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis, Clin Cancer Res, 9, 2620 Van Doornum, 2003, Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites, Br J Cancer, 88, 1095, 10.1038/sj.bjc.6600870 Smith, 2004, Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers, Int J Cancer, 108, 766, 10.1002/ijc.11633 Wiest, 2002, Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control, Oncogene, 21, 1510, 10.1038/sj.onc.1205214 Andl, 1998, Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control, Cancer Res, 58, 5 Li, 2004, The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil, Head & Neck, 26, 1, 10.1002/hed.10335 Wilczynski, 1998, Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma, Am J Pathol, 152, 145 Braakhuis, 2004, Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus, J Natl Cancer Inst, 96, 998, 10.1093/jnci/djh183 Sisk, 2002, Bradford CR. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma, Head & Neck, 24, 841, 10.1002/hed.10146 van Houten, 2001, Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas, Int J Cancer, 93, 232, 10.1002/ijc.1313 Hafkamp, 2003, A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5–8, Int J Cancer, 107, 394, 10.1002/ijc.11389 Andersson, 2001, The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas, Br J Cancer, 85, 1153, 10.1054/bjoc.2001.2085 Zehbe, 1999, Codon 72 polymorphism of p53 and its association with cervical cancer, Lancet, 354, 218, 10.1016/S0140-6736(99)01914-5 Kawajiri, 1993, Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer, Carcinogenesis, 14, 1085, 10.1093/carcin/14.6.1085 Storey, 1998, Role of a p53 polymorphism in the development of human papillomavirus-associated cancer, Nature, 393, 229, 10.1038/30400 Zehbe, 2001, p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development, Cancer Res, 61, 608 Klug, 2001, TP53 polymorphism, HPV infection, and risk of cervical cancer, Cancer Epidemiol, Biomarkers & Prev, 10, 1009 Yang, 2001, Effect of p53 polymorphism on the susceptibility of cervical cancer, Gynecol Obste Invest, 51, 197, 10.1159/000052924 Nagpal, 2002, P53 codon 72 polymor-phism and susceptibility to development of human pap-illoma virus-associated cervical cancer in Indian women, J Clin Invest, 32, 943, 10.1046/j.1365-2362.2002.01096.x Kim, 2001, Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women, Am J Obstet & Gynecol, 184, 55, 10.1067/mob.2001.108329 Pegoraro, 2000, The p53 codon 72 polymorphism in black South African women and the risk of cervical cancer, Int J Obstet & Gynaecol, 107, 1164, 10.1111/j.1471-0528.2000.tb11118.x Rosenthal, 1998, p53 codon 72 polymorphism and risk of cervical cancer in UK, Lancet, 352, 871, 10.1016/S0140-6736(98)07357-7 Madeleine, 2000, The p53 Arg72Pro polymorphism, human papillomavirus and invasive squamous cell cervical cancer, Cancer Epidemiol Biomarkers & Prev, 9, 225 Park, 2001, Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins, Int J Cancer, 91, 822, 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0 Prabhu, 1998, Somasundaram K, Satyamoorthy K, Herlyn M, El-Deiry WS. p73beta, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells, Int J Oncol, 13, 5 Kaghad, 1997, Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers, Cell, 90, 809, 10.1016/S0092-8674(00)80540-1 Taniere, 2000, TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in south Thailand, Int J of Cancer, 88, 223, 10.1002/1097-0215(20001015)88:2<223::AID-IJC12>3.0.CO;2-G Bahnassy, 2005, Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival, Pathol Int, 55, 53, 10.1111/j.1440-1827.2005.01804.x Khurshid, 1998, Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma, J Pakistan Med Assoc, 48, 138 Dellas, 1997, Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia, Int J Cancer, 74, 421, 10.1002/(SICI)1097-0215(19970822)74:4<421::AID-IJC10>3.0.CO;2-C Skomedal, 1999, TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus, J Pathol, 187, 556, 10.1002/(SICI)1096-9896(199904)187:5<556::AID-PATH294>3.0.CO;2-Y Bond, 2004, A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans, Cell, 119, 591, 10.1016/j.cell.2004.11.022 Sherr, 1995, D-type cyclins, Trends in Biochem Sci, 20, 187, 10.1016/S0968-0004(00)89005-2 Hosokawa, 1997, Cyclin D1 (PRAD1) alternative transcript b: full-length cDNA cloning and expression in breast cancers, Cancer Lett, 113, 123, 10.1016/S0304-3835(97)04605-3 Serrano, 1993, A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.[see comment], Nature, 366, 704, 10.1038/366704a0 Sano, 1998, Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions, Am J Pathol, 153, 1741, 10.1016/S0002-9440(10)65689-1 Klaes, 2001, Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri, Intl J Cancer, 92, 276, 10.1002/ijc.1174 Kanao, 2004, Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer, Cancer Lett, 213, 31, 10.1016/j.canlet.2004.03.030 Slebos, 2006, Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma, Clin Cancer Res, 12, 701, 10.1158/1078-0432.CCR-05-2017 Sauroja, 2000, Analysis of G(1)/S checkpoint regulators in metastatic melanoma, Genes, Chromosomes & Cancer, 28, 404, 10.1002/1098-2264(200008)28:4<404::AID-GCC6>3.0.CO;2-P Lindel, 2001, Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma, Cancer, 92, 805, 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9 Mellin, 2004, Occurrence of human papillomavirus is a positive factor in tonsillar cancer. Reduced risk of recurrence and longer survival, Lakartidningen, 101, 2794 Li, 2003, Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil, Int J Cancer, 106, 553, 10.1002/ijc.11261 Ringstrom, 2002, Human papillomavirus type 16 and squamous cell carcinoma of the head and neck, Clin Cancer Res, 8, 3187 Mellin, 2002, Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer, Int J Cancer, 102, 152, 10.1002/ijc.10669 Hafkamp, 2004, Role of human papil-lomavirus in the development of head and neck squamous cell carcinomas, Acta Oto-Laryngologica, 124, 520, 10.1080/00016480310016893 Badaracco, 2000, Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters, Anticancer Res, 20, 1301 Mellin, 2000, Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival, Int J Cancer, 89, 300, 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G Schwartz, 2001, Human papillomavirus infection and sur-vival in oral squamous cell cancer: a population-based study, Otolaryngol-Head & Neck Surg, 125, 1, 10.1067/mhn.2001.116979 Pintos, 1999, Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract, Cancer, 85, 1903, 10.1002/(SICI)1097-0142(19990501)85:9<1903::AID-CNCR4>3.0.CO;2-6 Báez, 2004, High frequency of HPV16-associated head and neck squamous cell carcinoma in the Puerto Rican population, Head Neck, 26, 778, 10.1002/hed.20046 Clayman, 1994, Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival, Arch Otolaryngol–Head & Neck Surg, 120, 743, 10.1001/archotol.1994.01880310047009 Koskinen, 2003, Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck, Int J Cancer, 107, 401, 10.1002/ijc.11381 Tsuda, 2003, Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm, Gynecol Oncol, 91, 476, 10.1016/j.ygyno.2003.08.019 Kim, 2005, Aberrant cell cycle regulation in cervical carcinoma, Yonsei Med J, 46, 597, 10.3349/ymj.2005.46.5.597 Butz, 1999, Induction of the p53-target gene GADD45 in HPV-positive cancer cells, Oncogene, 18, 2381, 10.1038/sj.onc.1202557 Huang, 1996, Abrogation of P53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation, Int J Radiat Biol, 70, 151, 10.1080/095530096145148 DeWeese, 1997, Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not ra-diosensitivity of carcinoma cells treated with low-dose-rate radiation, Int J Radiat Oncol Biol Phys, 37, 145, 10.1016/S0360-3016(96)00448-8 Liu, 2000, Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer, J Virol, 74, 2888, 10.1128/JVI.74.6.2888-2894.2000 Kozomara, 2005, p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival, J Cranio-Maxillo-Facial Sur, 33, 342, 10.1016/j.jcms.2005.05.004 Wittekindt, 2005, Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival, Adv Oto-Rhino-Laryngol, 62, 72 Weinberger, 2006, Molecular classification identifies a subset of human papillomavirus–associated oropharyngeal cancers with favorable prognosis, J Clin Oncol, 24, 736, 10.1200/JCO.2004.00.3335 Pytynia, 2004, Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck, J Clin Oncol, 22, 3981, 10.1200/JCO.2004.02.133